By The Registry Staff Another firm in the Bay Area is taking steps to exit its lease. Graphite Bio, a gene editing company, has opted to pay $58 million to terminate its lease at its South San Francisco headquarters, according to a report from The Real Deal. Graphite Bio had committed in January 2022 to […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Employee-owned general contractor Skyline Construction has brought veteran Silicon Valley builder Steve...
ByThe RegistryOctober 26, 2026Corona del Mar-based Hanley Investment Group Real Estate Advisors has absorbed the...
ByThe RegistryOctober 26, 2026A San Francisco private equity firm has paid more than $100 million...
ByThe RegistryOctober 26, 2026Rancho Cordova's City Council is set to decide whether to back KozPure...
ByThe RegistryOctober 26, 2026